Загрузка...
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
Invariant natural killer T (iNKT) cells have the capacity to amplify adaptive immune responses by licensing antigen-presenting cells. A simple vaccine consisting of whole tumor cells pulsed with an iNKT-cell agonist efficiently delivers antigens plus adjuvants to endogenous dendritic cells and has p...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654595/ https://ncbi.nlm.nih.gov/pubmed/23734325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23789 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|